Lifecore Biomedical, Inc. LFCR Income Statement
| Q4 '26 | Q2 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $23.19M-36.4% | $31.11M-4.5% | $36.44M-3.8% | $35.15M-1.5% | $32.56M+8.0% | ||
| $18.73M-16.6% | $23.32M+8.6% | $22.46M+9.0% | $25.31M+6.3% | $21.48M+6.4% | ||
| $4.46M-68.1% | $7.79M-29.7% | $13.98M-19.0% | $9.85M-17.2% | $11.08M+11.3% | ||
| 19.2%-19.1pp | 25%-9.0pp | 38.4%-7.2pp | 28%-5.3pp | 34%+1.0pp | ||
| $1.22M-42.1% | $1.96M+2.0% | $2.1M-2.7% | $2.05M-5.8% | $1.92M-8.3% | ||
| $7.92M-11.8% | $8.9M-20.0% | $8.98M-26.5% | $9.98M+1.3% | $11.12M+19.0% | ||
| -$4.67M— | -$3.07M-56.6% | —— | -$9.03M-909% | -$1.96M-32.1% | ||
| -20.1%— | -9.9%-3.8pp | —— | -25.7%-23.2pp | -6%-1.1pp | ||
| —— | —— | —— | —— | —— | ||
| $110K— | $110K+136% | —— | $333K+141% | -$304K+68.6% | ||
| -$14.94M-1,241% | -$9.66M-47.9% | -$1.11M— | -$14.78M-199% | -$6.53M-146% | ||
| $43K+30.3% | $333K+674% | $33K— | -$8K-104% | $43K+166% | ||
| -$14.98M-1,206% | -$9.99M-52.0% | -$1.15M— | -$14.77M-194% | -$6.57M-146% | ||
| -64.6%-61.4pp | -32.1%-11.9pp | -3.1%— | -42%-85.8pp | -20.2%-67.3pp | ||
| -$0.43-1,333% | -$0.29-16.0% | -$0.03— | -$0.42-200% | -$0.25-164% | ||
| -$2.36M-395% | -$1.09M-1,378% | $800K— | -$6.95M-726% | $85K-70.0% | ||
| -10.2%-12.4pp | -3.5%-3.8pp | 2.2%— | -19.8%-22.9pp | 0.3%-0.7pp | ||
| -$4.67M-319% | -$3.07M-56.6% | -$1.11M— | -$9.03M-909% | -$1.96M-32.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lifecore Biomedical, Inc.'s revenue?
- Lifecore Biomedical, Inc. (LFCR) generated $125.9M in revenue over the trailing twelve months, down 3.8% year over year.
- Is Lifecore Biomedical, Inc. profitable?
- Lifecore Biomedical, Inc. is not currently profitable: it reported a net loss of $40.9M over the trailing twelve months, a -30.0% net margin.
- What are Lifecore Biomedical, Inc.'s profit margins?
- Gross margin is 31.3% and operating margin is -14.5%, with a -30.0% net margin.
- What is Lifecore Biomedical, Inc.'s earnings per share?
- Lifecore Biomedical, Inc.'s diluted EPS over the trailing twelve months is $-1.17.
- Where does Lifecore Biomedical, Inc.'s income statement data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
